AKBA: Akebia Therapeutics, Inc. Stock

by  •  • Comments Off on AKBA: Akebia Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 732.32
Enterprise Value ($M) 860.23
Book Value ($M) -49.19
Book Value / Share -0.21
Price / Book -14.89
NCAV ($M) -156.02
NCAV / Share -0.66
Price / NCAV -4.69

Profitability (mra)
Return on Invested Capital (ROIC) -0.50
Return on Assets (ROA) -0.31
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.21
Current Ratio 1.41

Balance Sheet (mrq) ($M)
Current Assets 113.83
Assets 220.67
Liabilities 269.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 160.18
Operating Income -46.21
Net Income -69.41
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.66
Cash from Investing -0.03
Cash from Financing 49.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Satter Muneer A 2.60 -64.53
11-08 13G BlackRock, Inc. 7.20 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 848,546 4,725,850 17.96
2025-04-10 1,427,685 6,964,276 20.50
2025-04-09 1,170,799 7,230,222 16.19
2025-04-08 1,094,043 3,565,759 30.68
2025-04-07 702,650 3,899,695 18.02

(click for more detail)

Similar Companies
AGEN – Agenus Inc. AIMD – Ainos, Inc.
AKAN – Akanda Corp. ALBT – Avalon GloboCare Corp.
ALDX – Aldeyra Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io